Nakhle Saba has Hematopoietic Cell Transplantation And Cellular Therapy as his primary medical specialty. Their primary office is: 1415 Tulane Ave in New Orleans, Louisiana.
They're a part of the: Administrators Of The Tulane Educational Fund medical group which has around 380 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2005 (around 19 years of experience). They are listed as doing telehealth appointments.
Nakhle Saba
Administrators Of The Tulane Educational Fund
1415 Tulane Ave
New Orleans, Louisiana 70112
-
Enter a starting address:
Additional Medical Specialties Include:
INTERNAL MEDICINE
Medical School: Sorry, his university is not listed
Graduation Year: 2005
The Primary Medical Specialty for Nakhle Saba is listed as: Hematopoietic Cell Transplantation And Cellular Therapy
Approximate Years of Experience: 19
PAC (PECOS ID)#: 6406072586
NPI #: 1275714669
NPI Created On: 11/14/2007
NPI Last Updated Listed as: 03/20/2019
Primary Taxonomy Code: 174400000X
License Number:
MD.205210
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: ENGLISH, English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $2,000
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 788064887
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $4,100
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 788064895
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $750
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 788064889
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $112
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788064891
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $48
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Travel and Lodging City: MIAMI
Travel and Lodging State: FL
Travel and Lodging Country: United States
Third party is a Charity:: No
Record ID:: 788064893
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $1,500
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 788064897
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $125
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788064899
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $3,100
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 788064901
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $125
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788064903
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $3,100
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 788064905
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
1415 Tulane Ave
New-orleans, LA
Administrators Of The Tulane Educational Fund
1415 Tulane Ave
New Orleans La 70112-2600
Administrators Of The Tulane Educational Fund
Pulmonary Disease
1415 Tulane Ave
New Orleans La 70112-2600
Administrators Of The Tulane Educational Fund
Pathology
2000 Canal St
New Orleans La 70112-3018
Administrators Of The Tulane Educational Fund
Pathology
1415 Tulane Ave
New Orleans La 70112-2600
Administrators Of The Tulane Educational Fund
Nurse Practitioner
1415 Tulane Ave
New Orleans La 70112-2600
Administrators Of The Tulane Educational Fund
Obstetrics/gynecology
1415 Tulane Ave
New Orleans La 70112-2600
Administrators Of The Tulane Educational Fund
Physician Assistant
View all 380 members of Administrators Of The Tulane Educational Fund medical group